Jounce Therapeutics (JNCE) Financials

$1.88

$0.00 (0.00%)

As on 05-May-2023 09:30EDT

Market cap

$102 Mln

Revenue (TTM)

$82 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	82.00	26.88	62.34	147.87	65.20	71.64
Cost of Revenue	--	--	--	25.88	31.17	29.98
Gross Profit	82.00	26.88	62.34	147.87	34.03	41.66
Operating Expenses	134.24	117.96	107.46	95.06	96.50	90.86
Operating Profit (EBIT)	-52.24	-91.06	-45.12	52.82	-31.29	-19.22
Other Income	1.46	0.20	1.29	4.05	3.96	2.81
Profit before Tax	-50.78	-90.86	-43.83	56.87	-27.33	-16.41
Provision for Tax	0.14	0.02	0.01	0.05	0.05	0.04
Profit after Tax (Net Income)	-50.92	-90.87	-43.84	56.82	-27.38	-16.44
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-50.92	-90.87	-43.84	56.82	-27.38	-17.24

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	183.11	223.81	211.29	174.59	104.13	167.11
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.87	9.99	13.62	16.89	44.78	67.00
Current Liabilities	23.57	18.90	19.32	14.40	65.55	62.55
Total Liabilities	212.55	252.70	244.24	205.88	214.45	296.66

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	15.32	61.87	32.85	32.19	22.24	41.06
Current Assets	197.23	190.83	211.39	173.70	192.21	255.60
Total Assets	212.55	252.70	244.24	205.88	214.45	296.66
Total Debt*	10.02	13.69	16.89	19.79	0.06	0.06
Net Current Assets	173.66	171.93	192.07	159.30	126.66	193.05

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-28.88	-83.49	-27.79	-30.13	-63.61	-90.74
Cash Flow from Investing Activities	83.48	-60.51	51.30	31.38	86.41	-38.02
Cash from Financing Activities	0.44	92.04	70.74	4.08	1.55	107.47
Net Cash Inflow / Outflow	55.04	-51.96	94.25	5.34	24.35	-21.29

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-0.98	-1.82	-1.25	1.67	-0.83	-0.55
Cash EPS ($)	-0.94	-1.76	-1.16	1.78	-0.71	-0.40
Adjusted Book Value ($)	3.52	4.48	6.04	5.14	3.16	5.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.56	-1.67	-0.79	-0.89	-1.93	-3.02
Free Cash Flow per Share ($)	-0.57	-1.68	-0.80	-0.92	-1.97	-3.53

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-23.65	-39.03	-20.75	38.06	-20.18	-13.76
ROE (%)	-25.03	-41.77	-22.72	40.77	-20.19	-13.76
ROA (%)	-21.89	-36.57	-19.48	27.04	-10.71	-5.79
EBIT Margin (%)	-63.71	-338.75	-72.37	35.72	-41.92	-22.90
Net Margin (%)	-61.01	-335.58	-68.90	37.40	-39.59	-22.09
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	2.05	-0.57	-0.58	1.27	-0.09	0.93
EBIT Growth (%)	42.63	-101.82	-185.42	293.24	-66.59	-19.73
Net Profit Growth (%)	43.97	-107.27	-177.16	307.54	-66.51	-20.00
EPS Growth (%)	0.46	-0.45	-1.75	3.01	-0.51	0.92
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-1.13	-4.59	-5.59	5.22	-4.06	-23.26
Price / Book Value	0.32	1.87	1.16	1.70	1.07	2.29
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.43	92.33	-1.33	2.61	3.34	-12.26
Close Price ($)	1.11	8.35	7.00	8.73	3.37	12.75
High Price ($)	8.80	14.84	11.72	10.00	29.25	29.29
Low Price ($)	0.58	5.03	2.85	2.79	2.66	11.05
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.05	0.06	0.08	0.11	0.00	0.00
Short term debt to equity ratio	0.02	0.02	0.02	0.02	--	--
Current Ratio	8.37	10.10	10.94	12.06	2.93	4.09
Quick Ratio	--	--	--	--	--	4.09
Interest Coverage	-35.83	-30.09	-9.62	6.68	--	--

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	0.37	0.16	0.47	0.63	24.71
Asset Turnover	0.35	0.11	0.28	0.70	0.26	0.25
Receivable days	0.45	1.36	2.34	1.38	50.75	46.94
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	40.45	35.86	38.74
Cash Conversion Cycle	--	--	--	--	14.89	8.20